Displaying 641 - 660 of 948
| Contract Number | Brand Code | Drug | LAgent Code | Drug Contract Start Date | Drug Contract End Date | Formulary Category | Package Size | Protocol Monthly Max | Package Price | Contract Changed | Change Date | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 | 1941B | MULTISTIX 10SG STRP (SHD) DIAGNOSTIC URINE | AHI | 2026-04-01 | B | 100'S | 0 | 58.91 | Name Change | 2026-02-05 | |||
| 42 | 4253AX | MUPIROCIN 2% OINT (CHC) | STO | 2026-04-01 | BQ | 15G | 2 | 2.56 | Add to Contract | 2026-03-05 | |||
| 40 | 3681V | NALOXONE 0.4MG/ML AMP (RTM/PHA) | PHA | 2023-03-20 | 2024-03-31 | 10'S | 57.86 | Price Change | 2023-02-14 | ||||
| 40 | 3681T | NALOXONE 0.4MG/ML INJ (MON/PHA) | PHA | 2023-03-20 | 2024-03-31 | BQ | 5X1ML | 13.54 | Delete from contract | 2023-02-14 | |||
| 40 | 3681G | NALOXONE 0.4MG/ML INJ (RTM/PHA) | PHA | 2022-04-01 | 2024-03-31 | BQ | 10X1ML | 49.25 | Add to Contract as Cat B | 2023-02-22 | |||
| 41 | 1421CM | NAPA 500MG TAB (BEX) PARACETAMOL | AHI | 2024-04-01 | 2026-03-31 | A | 510'S | 180 | 17.32 | 2023-10-27 | |||
| 40 | 35311 | NATELE CAP (BSP/AHI) MULTIVITAMINS + M (C) | AHI | 2022-10-01 | 2023-02-20 | C | 28'S | 14.9 | Price Change | 2023-02-02 | |||
| 40 | 35311 | NATELE CAP (BSP/AHI) MULTIVITAMINS PRE (C) | AHI | 2023-02-21 | 2024-03-31 | C | 28'S | 15.33 | Add to Contract as Cat C | 2023-02-21 | |||
| 40 | 35311 | NATELE CAP (BSP/AHI) MULTIVITAMINS PRENATAL | AHI | 2022-04-01 | 2022-09-30 | C | 28'S | 0 | 13.97 | 2022-03-29 | |||
| 41 | B4512 | NATRIXAM 10MG|1.5MG MR TAB (SER) A (C) | STO | 2024-06-01 | 2026-03-31 | C | 30'S | 30 | 7.39 | 2024-06-01 | |||
| 41 | B4512 | NATRIXAM 10MG|1.5MG MR TAB (SER) AMLODIPINE|INDAPAMIDE | STO | 2024-04-01 | 2024-05-31 | A | 30'S | 30 | 7.39 | 2024-04-30 | |||
| 41 | B4514 | NATRIXAM 10MG|1.5MG MR TAB (SER) AMLODIPINE|INDAPAMIDE | COL | 2024-04-01 | 2024-05-31 | A | 30'S | 30 | 7.39 | 2024-04-30 | |||
| 41 | B4514 | NATRIXAM 10MG|1.5MG MR TAB (SER) AMLODIPINE|INDAPAMIDE (C) | COL | 2024-06-01 | 2026-03-31 | C | 30'S | 30 | 7.39 | 2024-06-01 | |||
| 41 | B4511 | NATRIXAM 5MG|1.5MG MR TAB (SER) AM (C) | STO | 2024-06-01 | 2026-03-31 | C | 30'S | 30 | 7.39 | 2024-06-01 | |||
| 41 | B4513 | NATRIXAM 5MG|1.5MG MR TAB (SER) AM (C) | COL | 2024-06-01 | 2026-03-31 | C | 30'S | 30 | 7.39 | 2024-06-01 | |||
| 41 | B4511 | NATRIXAM 5MG|1.5MG MR TAB (SER) AMLODIPINE|INDAPAMIDE | STO | 2024-04-01 | 2024-05-31 | A | 30'S | 30 | 7.39 | 2024-04-30 | |||
| 41 | B4513 | NATRIXAM 5MG|1.5MG MR TAB (SER) AMLODIPINE|INDAPAMIDE | COL | 2024-04-01 | 2024-05-31 | A | 30'S | 30 | 7.39 | 2024-05-01 | |||
| 42 | 0692P | NEOSTIGMINE 2.5MG/ML INJ (FSB) | STO | 2026-04-01 | BQ | 10X1ML | 0 | 7.80 | Add to Contract | 2026-03-05 | |||
| 41 | 0694B | NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ) | COL | 2024-04-01 | 2024-07-19 | BQ | 10X5ML | 0 | 101.04 | 2024-07-19 | |||
| 41 | 0694B | NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ) | COL | 2024-07-20 | 2026-03-31 | BQ | 10X5ML | 0 | 86.64 | 2024-07-19 | |||